The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

The FDA banned the controversial red dye no. 3, which gives food and drinks a bright, cherry red color. The ban is a response to a 2022 petition ... drugs have a compliance date of Jan. 18 ...

The proposed rule, if finalized, would establish a compliance date of ... to releasing the FOP proposed rule, FDA also issued a final rule updating the definition of the implied nutrient content ...

That doesn't mean the pouches are now "FDA approved" as drugs intended to treat ... A study published in the journal Tobacco Control in 2022 found that 26 of 44 sampled nicotine pouch products ...

it does not mean these tobacco products are safe, nor are they 'FDA approved,'" the agency cautioned in its statement on Thursday. "There is no safe tobacco product; youth should not use tobacco ...

which was first approved by the FDA in 1969. FDA bans use of Red No. 3 dye in food, drinks The FDA's Jan. 15 decision was in response to a 2022 petition from health groups and activists that cited ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

The move could mean ... approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA.

A routine tech checkup revealed the algorithm decayed during the COVID-19 pandemic, getting 7 percentage points worse at predicting who would die, according to a 2022 study. There were likely real ...